BN Business News
Añadir empresa →
Esta traducción se está preparando. Mientras tanto, mostramos temporalmente la versión original en inglés.

Negocios · 12/11/20191 min de lectura

Haemonetics Manufacturing, Inc.; Withdrawal of Approval of Abbreviated New Drug Application of Anticoagulant Citrate Dextrose Solution A, USP

Traducción automática local · Idioma original de la fuente

Resumen

The Food and Drug Administration (FDA or Agency) is withdrawing approval of abbreviated new drug application (ANDA) BA 710497/0 for Anticoagulant Citrate Dextrose Solution A, USP (ACD-A), In Plastic Bags, held by Haemonetics Manufacturing, Inc. Haemonetics Manufacturing, Inc., requested in writing that the Agency's approval of the application be withdrawn because the drug is no longer being marketed and has waived its opportunity for a hearing.

Idioma original de la fuente: Federal Register — Food and Drug AdministrationAbrir el comunicado original →